.... In contrast, disruptions in isoform expression, as observed in some drug-resistant lines (e.g., UACC-812, which shifted toward ISO 5–13), may contribute to resistance against HER2-targeted therapies. However, other mechanisms (e.g., the SLX4 mutation in BT-474 and additional...